- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4743 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
Patent holdings for IPC class A61K 31/4743
Total number of patents in this class: 106
10-year publication summary
|
9
|
4
|
6
|
1
|
7
|
5
|
8
|
6
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20501 |
6 |
| Arbutus Biopharma Corporation | 190 |
4 |
| Symrise AG | 1687 |
4 |
| Bristol-myers Squibb Company | 4864 |
3 |
| Novartis AG | 11234 |
2 |
| Amgen Inc. | 3911 |
2 |
| Korea Institute of Science and Technology | 2076 |
2 |
| Albany Molecular Research, Inc. | 64 |
2 |
| Case Western Reserve University | 1774 |
2 |
| FibroGen, Inc. | 162 |
2 |
| Genzyme Corporation | 1215 |
2 |
| Hanmi Holdings Co., Ltd | 20 |
2 |
| Hanmi Pharmaceutical Co. Ltd. | 33 |
2 |
| KG Acquisition LLC | 4 |
2 |
| Oricula Therapeutics LLC | 2 |
2 |
| PTC Therapeutics, Inc. | 483 |
2 |
| Shionogi & Co., Ltd. | 886 |
2 |
| Trana Discovery, Inc. | 14 |
2 |
| University of Washington | 2263 |
2 |
| Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 118 |
2 |
| Other owners | 57 |